Atlas Trials

High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study

Clinical trial NCT01926132 · UNKNOWN

Trial details

NCT number
NCT01926132
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Fatigue
Start date
2013-08-01
Primary completion
2013-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.